Assessment timing and choice of outcome measure in determining treatment response in chronic inflammatory demyelinating polyneuropathy: A post hoc analysis of the <scp>PRISM</scp> trial-Reference-Cited by-同舟云学术

Assessment timing and choice of outcome measure in determining treatment response in chronic inflammatory demyelinating polyneuropathy: A post hoc analysis of the PRISM trial

Published:2022-09-27 Issue:5 Volume:66 Page:562-567
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Rajabally Yusuf A.¹²^ORCID,Ouaja Rabye³^ORCID,Kasiborski Fabrice³,Pujol Sonia³,Nobile‐Orazio Eduardo⁴

Affiliation:

1. Aston Medical School Aston University Birmingham UK

2. Inflammatory Neuropathy Clinic University Hospitals Birmingham Birmingham UK

3. LFB Les Ulis France

4. Neuromuscular and Neuroimmunology Service, IRCCS Humanitas Research Hospital, Department of Medical Biotechnology and Translational Medicine Milan University Milan Italy

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27713

Reference18 articles.

1. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

2. An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study

3. Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy

4. Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy

5. A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies